RETROGRADE APPROACH

Sunday, March 9, 2025

8:00 AM - 9:55 AM ET

Moderator(s)

Lorenzo Azzalini, MD, PhD, MSc

Interventional Cardiologist
University of Washington
Seattle, Washington, United States

No relationships to disclose
Kevin Croce, MD, PhD

Director of CTO and Complex PCI Programs
Brigham and Women's Hospital
Harvard Medical School
Boston, Massachusetts, United States

Disclosure information not submitted.

Disclosure(s):

Lorenzo Azzalini, MD, PhD, MSc: Abbott Vascular: Consulting Fees (e.g., advisory boards) (Ongoing); Abiomed: Consulting Fees (e.g., advisory boards) (Ongoing), Grant/Research Support (Ongoing); GE Healthcare: Consulting Fees (e.g., advisory boards) (Terminated, December 11, 2024); HeartFlow: Consulting Fees (e.g., advisory boards) (Ongoing); Reflow Medical: Consulting Fees (e.g., advisory boards) (Ongoing), Stock-privately held company (Ongoing); Shockwave Medical, Inc: Consulting Fees (e.g., advisory boards) (Ongoing); Teleflex: Consulting Fees (e.g., advisory boards) (Ongoing)

Carlo Di Mario, MD: BSC, Amgen, BCRI, PERC, NAMSA, BMS, Janssen, Regeneron: Grant/Research Support (Terminated, September 7, 2023)